In Tuscany, insulin prescriptions during pregnancy reached a peak increase of 722% during the third trimester between 2004 and 2010.
Notes on verification
Confirmed by peer-reviewed primary source (Charlton et al., PLOS ONE 2016) and corroborated by secondary summary (epicentro.iss.it), both reporting the same 722% figure for Tuscany's third-trimester insulin prescribing increase. [tier=silver indep_score=1.0 clusters=2 claim_tier=notable | framework convergence=single on EUROmediCAT multi-region prescription database study (Charlton et al. 2016) (upstreams: EUROmediCAT project, Charlton et al. 2016 PLOS ONE study using seven European prescription databases) — publishers independent, evidence may not be | kind=attributed eligibility=high]
Sources
- Farmacoepidemiologia documentazione in Europa (seed:health_and_medicine)
- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155737 (corroboration)
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871589/ (corroboration)